Compare PAHC & BTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PAHC | BTT |
|---|---|---|
| Founded | 1946 | 2012 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 2014 | N/A |
| Metric | PAHC | BTT |
|---|---|---|
| Price | $52.69 | $22.73 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $34.33 | N/A |
| AVG Volume (30 Days) | ★ 222.4K | 106.5K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | 0.92% | ★ 2.95% |
| EPS Growth | ★ 1883.33 | N/A |
| EPS | ★ 1.32 | N/A |
| Revenue | ★ $833,350,000.00 | N/A |
| Revenue This Year | $17.03 | N/A |
| Revenue Next Year | $3.82 | N/A |
| P/E Ratio | $39.62 | ★ N/A |
| Revenue Growth | ★ 4.12 | N/A |
| 52 Week Low | $16.16 | $20.20 |
| 52 Week High | $56.30 | $23.08 |
| Indicator | PAHC | BTT |
|---|---|---|
| Relative Strength Index (RSI) | 59.22 | 43.66 |
| Support Level | $37.09 | $22.48 |
| Resistance Level | $56.14 | $22.75 |
| Average True Range (ATR) | 2.28 | 0.16 |
| MACD | -0.16 | -0.02 |
| Stochastic Oscillator | 73.36 | 23.08 |
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Blackrock Municipal 2030 Target Term Trust is a United States-based closed-end management investment company. The investment objective of the company is to provide current income exempt from regular federal income tax and to return $25.00 per common share to holders of common shares. The trust seeks to achieve its investment objectives by investing a majority of its assets in municipal bonds exempt from U.S. federal income taxes.